Imfinzi for Biliary Tract Cancers

Imfinzi (durvalumab) as a First-Line Treatment Option with Gemcitabine and Cisplatin for Locally Advanced or Metastatic Biliary Tract Cancers.

Speaker:
Maen Abdelrahim
Associate Professor of Medicine-Oncology
Houston Methodist Oncology Partners

Location:
Morton's the Steakhouse
2222 McKinney Avenue
Dallas, Tx 75201

November 10, 2022
6:30-8:00pm CST

RSVP by 11/7/22:
Alison Dent 214-957-2022
James Brooks 817-808-7878

This is not a chapter meeting.

Imfinzi_11_10_22_invite.pdf